UK based biopharmaceutical company SiSaf closes $4.3 million interim funding round
SiSaf’s Chairwoman and Chief Executive Officer, Suzanne Saffie-Siebert featured on BBC Radio 4’s ‘In Business’
Next-gen silicon nanotechnology drug delivery company SiSaf raises $3.5 million in Series A Funding
Silicon Valley Investors Lead Funding Round in SiSaf
« Previous Page
Next Page »
Find out more.
Okay, thank you